Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
To be eligible for the study, patients must be taking corticosteroids daily for chronic pulmonary sarcoidosis and lung impairment. As many as 90 accepted patients will receive infusion therapy every two weeks for 12 weeks, take CT and PET scans and submit questionnaires. Patients interested in participating in the trial should contact the Clinical Trials Office at 212-241-9538 or visit http://www.mssm.edu/research/resources/office-of-clinical-research.
The Phase I and II clinical trials have been funded by Pfizer.
The Mount Sinai Hospital / Mount Sinai School of Medicine
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Respiratory / Asthma category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
The Mount Sinai Hospital / Mount Sinai School of M. "Clinical Trial To Treat Chronic Pulmonary Sarcoidosis Enrolling Patients Now." Medical News Today. MediLexicon, Intl., 1 Feb. 2013. Web.
23 Apr. 2014. <http://www.medicalnewstoday.com/releases/255651>
The Mount Sinai Hospital / Mount Sinai School of M. (2013, February 1). "Clinical Trial To Treat Chronic Pulmonary Sarcoidosis Enrolling Patients Now." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/255651.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.